Avrio Genetics is a Health Care startup that was founded in 2017. The company offers a unique single-cell whole genome sequencing service, leveraging its patented MALBAC technology to enable comprehensive genomic analysis. This innovative approach boosts nucleic acids to microgram levels, supporting physicians and patients worldwide in making informed medical decisions. In addition to this service, Avrio Genetics provides an extensive range of reproductive and personalized genetic testing products and solutions. Currently, there is no publicly available information about the company's headquarter, last investment, or the involved investors.
There is no investment information
No recent news or press coverage available for Avrio Genetics.
We care about your data, and we'd love to use cookies make your experience better.
